(Alliance News) - Proteome Sciences PLC on Friday said it won a contract from an unnamed US biopharmaceutical company to use Proteome's mass spectrometry services. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday. Read More
(Alliance News) - Stock prices in London opened higher on Friday, as investors shook off nerves ahead of US inflation data this afternoon. Read More
(Alliance News) - Proteome Sciences PLC on Wednesday said it swung to a loss in 2023 on higher costs, and saw its revenue plunge on contract delays. Read More
Proteome Sciences PLC - London-based protein-focused drug development services provider - Completes installation and setup of equipment in its new lab in San Diego, California. The lab is now fully operational. Back in May, Proteome had announced it was expanding its proteomics services to the US. Says that the lab is "well placed to serve demand from a growing number of US customers looking to outsource proteomics projects to underpin their drug development programmes". Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday. Read More
(Alliance News) - Proteome Sciences PLC shares plummeted on Thursday, after it cut its revenue outlook for 2023 amid delays to projects. Read More
(Alliance News) - Proteome Sciences PLC on Monday launched SysQuant SCP, a commercial service for single cell proteomics using isobaric labelling reagents. Read More
(Alliance News) - The FTSE 100 edged higher at midday on Friday as all eyes turned to US Federal Reserve Chair Jerome Powell's address at Jackson Hole later in the day. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday. Read More
(Alliance News) - Proteome Sciences PLC on Friday reported higher costs in the first half of 2023 despite revenue remaining virtually flat, causing a swing to a loss. Read More
OnTheMarket PLC - Aldershot, Hampshire-based property listing website - Confirms that Tom Carter has started his role as chief financial officer. He is the former CFO of beauty brand business Brand Architekts Group PLC, from 2020 until just before starting his role at OnTheMarket. He was previously CFO at the London-based drug development services provider Proteome Science PLC. Read More
Proteome Sciences PLC - London-based drug development services provider - Says it has repaid in full its outstanding loan and associated interest, totalling GBP824,424, to Vulpes Investment Management Private Ltd, as originally announced in July 2018 and amended in March last year. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - Drug development services provider Proteome Sciences PLC said it is expanding its proteomics services to the US, opening a facility in San Diego. Read More
(Alliance News) - Proteome Sciences PLC on Tuesday said revenue was up by half, and profit multiplied in 2022. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday. Read More
(Alliance News) - Proteome Sciences PLC on Monday said it has experienced strong growth in both its services and TMT business, with a strong forward order book secured. Read More
Proteome Sciences PLC - drug development services provider - Achieves "cumulative sales milestone" with life sciences company Thermo Fisher Scientific Inc. Says a payment of GBP870,000 has been received by the company and will be recognised in the 2022 financial year. Proteome Sciences has an exclusive licence and distributor agreement with Thermo Scientific. Read More
Proteome Sciences PLC - drug development services provider - Says it has hired Abdelghani Omari as its new chief financial officer, effective on September 1. Says he will also become the director of the company. Proteome says Omari will join from speciality pharmaceutical company Paion AG, where he has been the chief financial officer since 2014. Read More